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In vivo administration of islet-activating protein to rats resulted in an increase in fat cell lipolysis in vitro, 
which was associated with almost complete resistance of adipocytes towards the antilipolytic effects of 
I@-phenylisopropyladenosine, prostaglandin Ez and nicotinic acid. Concomitantly, the inhibitory effects 
of these compounds on adenylate cyclase activity in membranes were impaired. In contrast, the 
antilipolytic action of insulin was not only preserved, but even augmented in cells from rats treated with 
islet-activating protein. The data suggest hat insulin exerts its antilipolytic effects via mechanisms which 
are different from those involved in the effects of prostaglandin Ez, N6-phenylisopropyladenosine and 
nicotinic acid. 
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1. INTRODUCTION 
Lipolysis is bidirectionally regulated [ 1,2]. Hor- 
mones and drugs which increase lipolysis usually 
also increase CAMP levels via stimulation of the 
membrane-bound adenylate cyclase. Conversely, 
most of the inhibitory hormones and drugs have 
been demonstrated to reduce CAMP levels and 
adenylate cyclase activity. The compounds causing 
inhibition of the rat fat cell adenylate cyclase in- 
clude adenosine and adenosine analogues, pros- 
taglandins of the E-series and nicotinic acid [3-S]. 
Insulin is the antilipolytic hormone par ex- 
cellence. No hormone appears to be more impor- 
tant in the regulation of adipocyte metabolism 
than insulin [l]. Insulin lowers the hormonally 
stimulated rise of CAMP levels in isolated 
adipocytes [6-81. This activity of insulin may be a 
result of an increase in the insulin-sensitive low K,,, 
CAMP phosphodiesterase activity [6] or could be 
related to an inhibitory effect of insulin on 
adenylate cyclase activity [7,8]. 
Recently, it has been shown that islet-activating 
protein (IAP), one of the toxins of Bordetellaper- 
tussis, impairs or abolishes the inhibitory effects of 
alpha-adrenergic agonists and muscarinic choliner- 
gic agonists on adenylate cyclase in pancreatic and 
myocardial membranes, respectively [9, lo]. It is 
now clear that IAP inactivates a regulatory subunit 
of the adenylate cyclase system (Ni) which is in- 
volved in hormone-induced inhibition of the en- 
zyme [ 11,121. The possibility that administration 
of IAP to rats may alter the sensitivity of their 
adipocytes to antilipolytic agents including insulin 
was, therefore, studied. 
2. MATERIALS AND METHODS 
Islet-activating protein was purified as in [13] 
from the supernatant of Bordeteila pertussis 
suspensions kindly donated by Drs L. Robbel and 
F. Backkolb (Behringwerke Marburg). N6-phenyl- 
isopropyladenosine (PIA) was from Boehringer 
Mannheim, and prostaglandin E2 (PG E2) and in- 
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sulin were from Serva AG (Heidelberg). Table 1 
Male rats (180-220 g) were treated once with 
IAP (4pg/kg i.v.). Three days later, the rats were 
killed by decapitation, and adipocytes were 
isolated by collagenase digestion [ 141. 
Effects of IAP on basal glycerol release in the absence 
or presence of adenosine deaminase (1pg/ml) alone or 
in combination with theophylline (1 mM) 
For metabolic studies, the isolated cells were 
suspended in Krebs-Henseleit bicarbonate buffer 
(pH 7.4) containing 40 g/l human serum albumin, 
5 mM of glucose and, when present, 1 pg/ml of 
adenosine deaminase either alone or in combina- 
tion with theophylline (1 mM) and hormones as in- 
dicated in the legends to fig. 1 and table 1. Incuba- 
tions were carried out under gas phase of 02 and 
CO2 (95 + 5) for 180 min at 37°C. Glycerol release 
was determined by a newly-developed biolumines- 
cent method in [ 151. 
Additions Glycerol 
release 
Control 
None 0.03 
Adenosine deaminase 1.2 
Adenosine deaminase 3.75 
+ theophylline 
Values are means of duplicate determinations. Glycerol 
release was determined in adipocytes from rats pre- 
treated with and without IAP as described in section 2 
Adenylate cyclase activity was determined essen- 
tially as in [ 161. The assay medium contained 50 
PM [32P]ATP (0.2-0.4&i/tube), 2 mM MgC12, 1 
PM GTP, 0.1 mM CAMP, 100 mM NaCl, 4 mM 
3-isobutyl-1-methyl-xanthine, 2 mg/ml bovine 
serum albumin, 0.4 mg/ml creatine kinase, 5 mM 
creatine phosphate as its tris (hydroxyme- 
thyl)aminomethane salt, and 50 mM triethanol- 
amine-HCl (pH 7.4) in a total volume of 0.1 ml. 
Reactions were started by addition of fat cell mem- 
branes (20-40 pug/tube) to the prewarmed reaction 
mixture and were performed for 10 min at 25°C. 
3. RESULTS 
Illustrated in fig. 1 are the effect of various an- 
tilipolytic agents on lipolysis in the presence of 
either adenosine deaminase alone (insulin, PIA) or 
in combination with theophylline (PGE2). All com- 
pounds tested caused a dose-dependent inhibition 
of lipolysis in fat cells obtained from non-treated 
animals. In contrast to controls, the inhibitory ef- 
fects of those agents known to affect lipolysis via 
inhibition of adenylate cyclase (PIA, PGE2) was 
impaired or abolished in fat cells from IAP-treated 
animals. The same qualitative pattern of effects 
was obtained with nicotinic acid (not shown). 
Table 1 shows the effects of IAP administration 
in vivo on basal glycerol release of isolated fat cells 
in the presence and absence of adenosine 
deaminase and theophylline. In cells from non- 
treated animals, basal lipolysis was hardly 
measurable (0.3 rmol. lo6 cells-‘. 180 min-‘). In- 
clusion of adenosine deaminase (1 pg/ml) resulted 
in a marked increase in glycerol release (1.2 
pmol. lo6 cells-’ .180 min-‘), which was further 
increased by simultaneous addition of theophylline 
(1 mM). IAP treatment caused a marked increase 
in lipolysis. In contrast to controls, adenosine 
deaminase had no stimulatory effect under these 
conditions, indicating that the antilipolytic effect 
of endogenously produced adenosine had been 
abolished by previous administration of IAP. 
Simultaneous addition of theophylline caused a 
further increment in glycerol release in cells from 
IAP-treated animals. 
Fig. 1. Influence of IAP treatment on the antilipolytic 
effects of PGE2, PIA and insulin, The medium contain- 
ed adenosine deaminase (1 pg/ml) either alone (PIA, in- 
sulin) or in combination with theophylline (1 mM, 
PGEz). Solid lines: controls; dotted lines: cells from 
IAP-treated rats. 
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A Control B IAP-tmated action of insulin was not only preserved, but even 
augmented after IAP treatment, which abolished 
the inhibitory effects of other antilipolytic agents 
such as PIA, PGE2 and nicotinic acid. 
Our results are in agreement with preliminary 
studies showing that pretreatment of hamsters with 
pertussis vaccine can reduce the inhibitory effects 
of various antilipolytic agents on CAMP levels and 
lipolysis in vitro [17]. They also explain results ob- 
tained with histamine-sensitizing factor (HSF), a 
pertussis toxin similar, or identical to IAP [9]. This 
toxin has been reported to reveal an antilipolytic 
effect of insulin under conditions where no such 
effect was seen in the absence of the toxin [18]. In 
the light of our findings, this permissive effect of 
HSF might in part be due to an increased insulin 
sensitivity induced by the toxin treatment. 
The actions of insulin on adipocyte metabolism 
are diverse and may be mediated via different 
mechanisms [ 191. From the present results, we can- 
not exclude that the antilipolytic effect of insulin is 
mediated via inhibition of adenylate cyclase, either 
directly by insulin receptor-mediated processes or 
indirectly via formation of low -M, mediators [20]. 
However, if insulin affects adenylate cyclase activi- 
ty, the mechanisms of action are clearly different 
from those responsible for inhibition of glycerol 
release by other antilipolytic compounds such as 
prostaglandin Ez, N6-phenylisopropyladenosine or 
nicotinic acid. 
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Fig. 2. Effects of various antilipolytic compounds on 
adenylate cyclase activity in adipocyte membranes ob- 
tained from control and IAP-treated animals. 
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Among the agents tested, only insulin was capable 
of inhibiting lipolysis in cells of IAP-treated 
animals. This latter hormone was even more po- 
tent in cells from IAP-rats than in adipocytes from 
non-treated controls. 
Fig. 2 shows the effects of insulin, PIA and 
PGE2 on adenylate cyclase activity in adipocyte 
membranes. Similar to lipolysis in intact cells, 
adenylate cyclase activity was dose-dependently 
decreased by PIA and PGE2. As in intact cells, the 
inhibitory effects of PIA, PGE2 and also of 
nicotinic acid (not shown) were almost completely 
abolished in adipocyte membranes of IAP-treated 
animals. Insulin failed to decrease CAMP forma- 
tion in adipocyte membranes of controls and IAP- 
treated rats. 
4. DISCUSSION 
These results show that pretreatment of rats with 
IAP abolishes the antilipolytic effects of PGE2, 
PIA and nicotinic acid. Concomitantly, the in- 
hibitory effects of these compounds on adenylate 
cyclase are almost completely lost (fig.2), in- 
dicating that the antilipolytic effects of PIA, PGE2 
and nicotinic acid are mediated via inhibition of 
adenylate cyclase. 
The mechanisms of insulin’s antilipolytic action 
appear to be different. Like others, we failed to 
obtain an inhibitory effect of the peptide hormone 
on adenylate cyclase under conditions where other 
antilipolytic compounds caused marked inhibition 
(fig.2). In addition, in intact cells the antilipolytic 
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